1 November 2021 in Journal of Gynecology Obstetrics and Human Reproduction
MRMohummad Hasan Raza Raja
+2
26 July 2022 in Electronic Journal of General Medicine
Aim: This research was aimed to observe apoptotic marker (caspase 3) levels in different groups after treatment with vitamin D in an animal model after inducing polycystic ovary syndrome (PCOS) with dehydroepiandrosterone (DHEA). Materials and Methods: 30 pre-pubertal female sprague dawley dams were recruited. The animals were distributed 10 each in control, PCOS and vitamin D treated groups. In control group, 0.2 ml of sesame oil was given. PCOS group was administered DHEA by the daily dose of 6 mg/kg for 30 days. In vitamin D treated group, animals were injected 6 mg/ kg/day DHEA daily and 120 ng 1, 25(OH) 2D3/100 g subcutaneously once a week. The occurrence of programmed cell death in PCOS by apoptotic marker (caspase 3) levels. Results: The results of this study showed significant weight gain, obesity, changes in caspase 3 levels in PCOS group as compared to control and vitamin D treated group. Conclusion: Administration of vitamin D (120 ng 1, 25(OH) 2D3/100) reduced body weight as well as improved the caspase 3 levels in PCOS induced animals. The results support the effect of vitamin D treatment for metabolic and reproductive characteristic features in PCOS females.
5 February 2024 in Journal of Ayub Medical College Abbottabad
MFMohammad Umair Farooqui
MSMuhammad Subhan Siddiqui
Background: Heat shock protein-27 is the microprotein released from renal parenchyma during diabetic oxidative stress, while microalbumin is the plasma protein that appears in urine in diabetic nephropathy. Methods: This case-control study was conducted from Jan to Sep 2021 in the Physiology department, BMC, BMCH, Quetta. The current study included 105 patients with an age range from 30-50 years and was divided into three groups: i) a control group of healthy participants, ii) a diabetic risk group: participants without signs of diabetic nephropathy and diabetic duration from 1-5 years, iii) diabetic nephropathy group: participants having >30 mg/dl of v microalbumin in urine and diabetic duration from 5-10 years. Results: There were significant mean differences between all groups with respect to anthropometric measurements except in height amongst all groups. Statistically significant mean differences were seen in the risk and nephropathy group with respect to serum FBG, RBG, and HbA1c. Elevated microalbumin levels in the diabetic nephropathy group (50.9±8.2) compared with the diabetic risk group (15.4±2.9). Similarly, higher levels of HSP-27 were seen in the diabetic nephropathy group (230.46±23.75) as compared with the diabetic risk group (117.60±14.50). Conclusion: HSP-27 is a better biomarker than microalbumin and may show early glomerular injury in the early diabetic stage of diabetic nephropathy
20 September 2024 in Discover Public Health
There is rising recognition of the importance of vitamin D (VD) in human reproduction. The vitamin D receptor (VDR) in the human genome is encoded by the V
19 May 2023 in Research Square
Background: WHO has declared Infertility as the fifth-highest serious global disability with prevalence of approximately 22% in Pakistan; 80% due to polycystic ovarian syndrome (PCOS). PCOS is characterized by “the presence of any two out of three criteria, that is oligo and/or anovulation, excess androgen activity and/or polycystic ovarian morphology on ultrasound”. Vitamin D deficiency (VDD) [serum 25(OH) D <20 ng/ml] is vital for female health and becoming public health problem even in sun-drenched cities. With high prevalence (58%) of VDD in Pakistani PCOS. The hypothesis: “VD supplementation can improve fertility by correcting in IR, ovulatory dysfunction, endometrial thickness and hyperandrogenism in primary infertile PCOS patients of our population”. We aim to evaluate impact of oral VD supplementation on fertility potential of VDD PCOS (VD <20 ng/ml) in a 2-years randomized clinical trial; Group-1 VDD control PCOS (n=100) and Group-2 VDD intervention group (n=100). Group-1will receive 1.5 g/day metformin therapy for 24 weeks. Group-2 will be given 50,000 I.U of VD once weekly for 8 weeks, followed by 50,000 I.U once every fortnight from 9- 24 weeks plus metformin therapy. Impact will be assessed by comparing trans-vaginal ultrasound (TVS; Day 12) at the start with TVS at end point (24 weeks) to observe change in dominantfollicle size (≥14 mm) and endometrial thickness (≥8 mm). Discussion: The proposed interventions will help to evaluate the impact of vitamin D supplementation on follicular maturation and endometrial thickness and PCOS parameters including lipid index and insulin resistance. Trial registration: ClinicalTrials.gov, NCT03989778
1 August 2020 in Journal of the College of Physicians and Surgeons Pakistan